Autoimmune diseases New spin-off Ahead Therapeutics SL to develop novel therapies for autoimmune diseases 18.04.2018

Ahead Therapeutics SL is the result of a joint research project with a strong nano component between the Germans Trias i Pujol Research Institute (IGTP), the ICN2 and ICREA. It was created to advance the development of therapies for autoimmune diseases and pursue their application in a clinical setting. Just a few months in, the […]

A graphene layer GRAPHENEA, a high-quality graphene producer 16.02.2018

GRAPHENEA, nanoGUNE’s first start-up company launched in April 2010 as a joint venture of private investors and nanoGUNE, has become a world leader in the production of high-quality graphene. In 2013, Repsol and the Spanish Center for Industrial Technology Development (CDTI) signed an agreement to invest one million euros in GRAPHENEA. Following the foundational agreement […]

ZeClinics Founders - Ignasi Sahún - Simone Calzolari - Davide D'Amico - Javier Terriente The biotechnology company ZeClinics receives a grant of €1.87M from the European Commission 10.02.2018

A grant awarded to ZeClininics allows it to develop and accelerate the commercialization of one of its flagship products: ZeCardio®, a predictive system for the analysis of the cardiovascular effects of drugs during the discovery phase. One of the most important challenges for biotech companies is to get enough funding to turn their most innovative […]

The Nano Electronic Diagnostic Array (NEDxA) NEDxA, commercialized by Genomica 09.02.2018

Institute for Bioengineering of Catalonia (IBEC) The Nano Electronic Diagnostic Array (NEDxA) is the result of the Joint Research Unit between IBEC’s Nanobioengineering group, led by Josep Samitier, and Genomica S.A.U. (Grupo Zeltia), the leading Spanish company in molecular diagnostics. NEDxA-HPV is a new in vitro diagnostics device for Human Papillomavirus (HPV) testing, a new […]

Avizorex Pharma Novel therapies for Dry Eye Syndrome (DES) acting on eye surface temperature-sensitive fibers

Novel therapies for Dry Eye Syndrome (DES) have been developed based on the research on the role of eye surface temperature-sensitive nerve fibers in tear film regulation. Dry eye is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. It is accompanied by increased osmolarity of the tear film and inflammation of the ocular surface. TRPM8 (transient receptor potential cation channel, subfamily […]